SLC7A11 and neoplasm: Targeted inhibition of SLC7A11 promotes intracellular lipid peroxide accumulation, induce tumor cell ferroptosis, and enhances sensitivity to immunotherapy, radiotherapy, and chemotherapy (Koppula et al., 2021; Yan et al., 2023).